drugset / Trial / NCT02052531
Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-06
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PAC-14028 | Unknown | 0.3 % | Topical |
| Subject | PAC-14028 | Unknown | 1 % | Topical |
Indications
No indication recorded.